Full Text View
Tabular View
No Study Results Posted
Related Studies
TDM of Generic Lopinavir/Ritonavir 200/50 mg
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2010 by The HIV Netherlands Australia Thailand Research Collaboration.
Recruitment status was  Active, not recruiting
Study NCT00802334   Information provided by The HIV Netherlands Australia Thailand Research Collaboration

First Received on May 29, 2008.   Last Updated on November 30, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV
Interventions listed in this trial
generic lopinavir/ritonavir
Additional drug interventions recognized in this trial
Lopinavir
Ritonavir
More general drug interventions related to this trial
Anti-HIV Agents
Anti-Infective Agents
Anti-Retroviral Agents
Antiviral Agents
Enzyme Inhibitors
HIV Protease Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Therapeutic Uses
Sponsors listed in this trial
The HIV Netherlands Australia Thailand Research Collaboration
The Government Pharmaceutical Organization


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services